Company Filing History:
Years Active: 1998
Title: The Innovations of Stephen Patrick Simmons
Introduction
Stephen Patrick Simmons is an accomplished inventor based in Overland Park, Kansas. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release medications. His innovative approach has led to the creation of a unique patent that addresses important medical needs.
Latest Patents
Simmons holds a patent for a controlled release carbonic anhydrase inhibitor. This patent describes a controlled release pharmaceutical composition in oral dosage unit form. It comprises a hard or soft shell capsule containing a filling made up of active spherical granules. These granules include a therapeutically effective amount of at least one carbonic anhydrase inhibitor active medicament, along with a pharmaceutically acceptable normally solid diluent. This diluent is designed to form a diffusable matrix for the carbonic anhydrase inhibitor active medicament, and it may also include an optional pharmaceutically acceptable excipient. The patent also outlines a method for the preparation and administration of this composition.
Career Highlights
Simmons is associated with American Cyanamid Company, where he has been able to apply his expertise in pharmaceutical innovations. His work has contributed to advancements in drug delivery systems, enhancing the effectiveness of treatments for various medical conditions.
Collaborations
Throughout his career, Simmons has collaborated with notable colleagues, including Wendy Ann Preston and Daniel Joseph Doyon. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Stephen Patrick Simmons is a notable inventor whose work in controlled release pharmaceuticals has made a significant impact in the medical field. His patent for a carbonic anhydrase inhibitor showcases his commitment to advancing healthcare solutions.